Karen Davies joined OraSure in 2024 as Senior Vice President of Research & Development and is responsible for the R&D efforts of Sherlock Biosciences, a wholly-owned subsidiary. A medical diagnostic and device development veteran, Ms. Davies has more than 30 years of experience driving innovation across a broad spectrum of diagnostic platforms, serving previously as Chief Development Officer for Sherlock Biosciences. Prior to Sherlock, she was at Quidel, where she served as Vice President of Instrument Systems and was responsible for product architecture and development, as well as Vice President of Business Transformation, where she was responsible for internal process improvement and global commercial communications associated with M&A transactions. During her career, Ms. Davies has held key leadership roles at organizations including Gen-Probe (Hologic), Abbott, and Dura Pharmaceuticals, serving as part of the launch team for multiple diagnostic platforms. She holds a Bachelor of Science degree in Mechanical Engineering from Stanford University.